1h Free Analyst Time
The publisher has been monitoring the POC molecular diagnostics market and it is poised to grow by $1.83 bn during 2022-2026, accelerating at a CAGR of 14.67% during the forecast period. The report on the POC molecular diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing geriatric population, increase in adoption of microarrays in genomics and proteomics, and increased focus on personalized medicine.
The POC molecular diagnostics market analysis includes the product, application segment, and geographic landscape.
The POC molecular diagnostics market is segmented as below:
By Product
- PCR
- Microarray and hybridization
By Application
- Infectious diseases
- Oncology
- Hematology and endocrinology
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the growing focus on technological advances as one of the prime reasons driving the POC molecular diagnostics market growth during the next few years. Also, the presence of government funding and a growing number of cancer cases worldwide will lead to sizable demand in the market.
The report on POC molecular diagnostics market covers the following areas:
- POC molecular diagnostics market sizing
- POC molecular diagnostics market forecast
- POC molecular diagnostics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading POC molecular diagnostics market vendors that include Abbott Laboratories, Becton Dickinson and Co., Binx Health Inc., Co-Diagnostics Inc., Danaher Corp., F. Hoffmann La Roche Ltd., gene drive plc, Lucira Health Inc., Molbio Diagnostics Pvt. Ltd., OraSure Technologies Inc., QIAGEN NV, QuantuMDx Group Ltd., Randox Laboratories Ltd., Robert Bosch GmbH, Siemens AG, Sysmex Corp., Talis Biomedical Corp., Thermo Fisher Scientific Inc., bioMerieux SA, and Quidel Corp. Also, the POC molecular diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Product
6 Market Segmentation by Application
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Vendor Landscape
11 Vendor Analysis
12 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global POC molecular diagnostics market: Abbott Laboratories, Becton Dickinson and Co., Binx Health Inc., Co-Diagnostics Inc., Danaher Corp., F. Hoffmann La Roche Ltd., gene-drive plc, Lucira Health Inc., Molbio Diagnostics Pvt. Ltd., OraSure Technologies Inc., QIAGEN NV, QuantuMDx Group Ltd., Randox Laboratories Ltd., Robert Bosch GmbH, Siemens AG, Sysmex Corp., Talis Biomedical Corp., Thermo Fisher Scientific Inc., bioMerieux SA, and Quidel Corp.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing focus on technological advances."
According to the report, one of the major drivers for this market is the growing geriatric population.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned
A selection of companies mentioned in this report includes:
- Abbott Laboratories
- Becton Dickinson and Co.
- binx Health Inc.
- Co-Diagnostics Inc.
- Danaher Corp.
- F. Hoffmann La Roche Ltd.
- genedrive plc
- Lucira Health Inc.
- Molbio Diagnostics Pvt. Ltd.
- OraSure Technologies Inc.
- QIAGEN NV
- QuantuMDx Group Ltd.
- Randox Laboratories Ltd.
- Robert Bosch GmbH
- Siemens AG
- Sysmex Corp.
- Talis Biomedical Corp.
- Thermo Fisher Scientific Inc.
- bioMerieux SA
- Quidel Corp.